156 related articles for article (PubMed ID: 32741142)
1. Efficacy of toluidine blue in the diagnosis and screening of oral cancer and pre-cancer: A systematic review and meta-analysis.
Kim DH; Song EA; Kim SW; Hwang SH
Clin Otolaryngol; 2021 Jan; 46(1):23-30. PubMed ID: 32741142
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of chemiluminescence in the diagnosis and screening of oral cancer and precancer: a systematic review and meta-analysis.
Kim DH; Lee J; Lee MH; Kim SW; Hwang SH
Braz J Otorhinolaryngol; 2022; 88(3):358-364. PubMed ID: 32847738
[TBL] [Abstract][Full Text] [Related]
3. How effective is toluidine blue for screening and diagnosis of oral cancer and premalignant lesions?
Mills S
Evid Based Dent; 2022 Mar; 23(1):34-35. PubMed ID: 35338328
[TBL] [Abstract][Full Text] [Related]
4. Methylene Blue as a Diagnosis and Screening Tool for Oral Cancer and Precancer.
Hwang SH; Kim SW; Song EA; Lee J; Kim DH
Otolaryngol Head Neck Surg; 2021 Feb; 164(2):271-276. PubMed ID: 32746769
[TBL] [Abstract][Full Text] [Related]
5. Autofluorescence imaging to identify oral malignant or premalignant lesions: Systematic review and meta-analysis.
Kim DH; Kim SW; Hwang SH
Head Neck; 2020 Dec; 42(12):3735-3743. PubMed ID: 32866310
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Narrowband Imaging and White-Light Endoscopy for Diagnosis and Screening of Nasopharyngeal Cancer.
Kim DH; Lee MH; Lee S; Kim SW; Hwang SH
Otolaryngol Head Neck Surg; 2022 May; 166(5):795-801. PubMed ID: 34311609
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of non-invasive diagnostic methods in the diagnosis and screening of oral cancer and precancer.
Kim DH; Kim SW; Hwang SH
Braz J Otorhinolaryngol; 2022; 88(6):937-947. PubMed ID: 33642212
[TBL] [Abstract][Full Text] [Related]
8. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Olfactory and Taste Symptoms in the Diagnosis of COVID-19: A Systematic Review and Meta-Analysis.
Kim DH; Kim SW; Stybayeva G; Lim SY; Hwang SH
Clin Exp Otorhinolaryngol; 2021 Aug; 14(3):312-320. PubMed ID: 33541033
[TBL] [Abstract][Full Text] [Related]
10. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
[TBL] [Abstract][Full Text] [Related]
11. Comparing the efficacy of chemiluminescence with lugol's iodine versus toluidine blue in the diagnosis of dysplasia in tobacco associated oral lesions - A diagnostic study.
Swathi KV; Maragathavalli G; Uma Maheswari TN
Indian J Dent Res; 2021; 32(4):459-466. PubMed ID: 35645072
[TBL] [Abstract][Full Text] [Related]
12. The light at the end of the tunnel? Can light-based tests increase the accuracy of our diagnoses of pre-cancerous/cancerous lesions?
Coll Y; Geddes A; Thomson E
Evid Based Dent; 2022 Mar; 23(1):16-17. PubMed ID: 35338319
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
[No Abstract] [Full Text] [Related]
14. The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review.
Rashid A; Warnakulasuriya S
J Oral Pathol Med; 2015 May; 44(5):307-28. PubMed ID: 25183259
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of autofluorescence and toluidine blue in the differentiation of oral dysplastic and neoplastic lesions from non dysplastic and neoplastic lesions: a cross-sectional study.
Petruzzi M; Lucchese A; Nardi GM; Lauritano D; Favia G; Serpico R; Grassi FR
J Biomed Opt; 2014; 19(7):76003. PubMed ID: 24996662
[TBL] [Abstract][Full Text] [Related]
16. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
[TBL] [Abstract][Full Text] [Related]
17. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
Awan KH; Morgan PR; Warnakulasuriya S
Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
[TBL] [Abstract][Full Text] [Related]
18. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
19. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions.
Cancela-Rodríguez P; Cerero-Lapiedra R; Esparza-Gómez G; Llamas-Martínez S; Warnakulasuriya S
J Oral Pathol Med; 2011 Apr; 40(4):300-4. PubMed ID: 21426401
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative Neural Monitoring for Early Vocal Cord Function Assessment After Thyroid Surgery: A Systematic Review and Meta-Analysis.
Kim DH; Kim SW; Hwang SH
World J Surg; 2021 Nov; 45(11):3320-3327. PubMed ID: 34191086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
